Literature DB >> 17570258

Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome.

Elizabeth Stein1, Harvey Kushner, Samuel Gidding, Bonita Falkner.   

Abstract

Despite higher rates of cardiovascular disease, African Americans have a more favorable lipid profile. The purpose of the study was to examine the association between plasma lipid concentrations and insulin resistance in African Americans and to determine if insulin resistance is present at a lower triglyceride (TG) threshold than is used for metabolic syndrome criteria. Data were examined on 185 nondiabetic African American men (n = 61) and women (n = 124), mean age, 39.8 years. Measurements included blood pressure, anthropometrics, oral glucose tolerance test, and insulin sensitivity (M) by insulin clamp. The relationship between lipids and insulin sensitivity was analyzed by correlation analysis and by comparing TG levels among tertiles of M. Despite relatively low mean (+/- SD) TG level (87.8 +/- 55.2 mg/dL), there were statistically significant correlations of M with TG (r = -0.23, P < .002), high-density lipoprotein cholesterol (HDL-C; r = 0.19, P < .01), and TG/HDL-C ratio (r = -0.23, P < .002). The correlations were strongest in men. Subjects with TG in an intermediate range (110-149 mg/dL) had insulin resistance equivalent to that of the high-TG group (>/=150 mg/dL). In African Americans, TG levels below the current metabolic syndrome threshold criterion are associated with insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570258      PMCID: PMC1950893          DOI: 10.1016/j.metabol.2007.02.008

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  36 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  A comparison of the skinfold method with extent of 'overweight' and various weight-height relationships in the assessment of obesity.

Authors:  J Womersley
Journal:  Br J Nutr       Date:  1977-09       Impact factor: 3.718

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women.

Authors:  Alice S Ryan; Barbara J Nicklas; Dora M Berman
Journal:  Obes Res       Date:  2002-05

5.  Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors.

Authors:  Fida Bacha; Rola Saad; Neslihan Gungor; Janine Janosky; Silva A Arslanian
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

6.  Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans.

Authors:  Heno F Lopes; Jason D Morrow; Milos P Stojiljkovic; Theodore L Goodfriend; Brent M Egan; Milos P Stoijiljkovic
Journal:  Am J Hypertens       Date:  2003-05       Impact factor: 2.689

Review 7.  The Metabolic Syndrome in African Americans: a review.

Authors:  W Dallas Hall; Luther T Clark; Nanette K Wenger; Jackson T Wright; Shiriki K Kumanyika; Karol Watson; Ella W Horton; John M Flack; Keith C Ferdinand; James R Gavin; James W Reed; Elijah Saunders; Welton O'Neal
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

Review 8.  The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.

Authors:  Gerald Reaven
Journal:  Endocrinol Metab Clin North Am       Date:  2004-06       Impact factor: 4.741

9.  Use of metabolic markers to identify overweight individuals who are insulin resistant.

Authors:  Tracey McLaughlin; Fahim Abbasi; Karen Cheal; James Chu; Cindy Lamendola; Gerald Reaven
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

10.  Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.

Authors:  Youlian Liao; Soonho Kwon; Sara Shaughnessy; Penny Wallace; Amy Hutto; Alicia J Jenkins; Richard L Klein; W Timothy Garvey
Journal:  Diabetes Care       Date:  2004-04       Impact factor: 19.112

View more
  20 in total

1.  Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial.

Authors:  Jeremy D Furtado; Hannia Campos; Anne E Sumner; Lawrence J Appel; Vincent J Carey; Frank M Sacks
Journal:  Am J Clin Nutr       Date:  2010-09-08       Impact factor: 7.045

2.  Interethnic Variation in Lipid Profiles: Implications for Underidentification of African-Americans at risk for Metabolic Disorders.

Authors:  Amy R Bentley; Charles N Rotimi
Journal:  Expert Rev Endocrinol Metab       Date:  2014-01-10

3.  Relationships of total adiponectin and molecular weight fractions of adiponectin with free testosterone in African men and premenopausal women.

Authors:  Jie Cui; XiangDong Wu; Jocelyn Andrel; Bonita Falkner
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11-15       Impact factor: 3.738

4.  The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth.

Authors:  J Warolin; K R Coenen; J L Kantor; L E Whitaker; L Wang; S A Acra; L J Roberts; M S Buchowski
Journal:  Pediatr Obes       Date:  2013-01-07       Impact factor: 4.000

Review 5.  Interethnic Differences in Serum Lipids and Implications for Cardiometabolic Disease Risk in African Ancestry Populations.

Authors:  Amy R Bentley; Charles N Rotimi
Journal:  Glob Heart       Date:  2017-05-17

6.  Adolescent and adult African Americans have similar metabolic dyslipidemia.

Authors:  Samuel S Gidding; Scott W Keith; Bonita Falkner
Journal:  J Clin Lipidol       Date:  2014-11-29       Impact factor: 4.766

Review 7.  Prevalence of metabolic syndrome and obesity-associated hypertension in the racial ethnic minorities of the United States.

Authors:  Bonita Falkner; Nicole D F H Cossrow
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

8.  Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans.

Authors:  Cristina Lara-Castro; Erin C Doud; Patrick C Tapia; Andres J Munoz; Jose R Fernandez; Gary R Hunter; Barbara A Gower; W Timothy Garvey
Journal:  Obesity (Silver Spring)       Date:  2008-09-25       Impact factor: 5.002

9.  Adiponectin regulates albuminuria and podocyte function in mice.

Authors:  Kumar Sharma; Satish Ramachandrarao; Gang Qiu; Hitomi Kataoka Usui; Yanqing Zhu; Stephen R Dunn; Raogo Ouedraogo; Kelly Hough; Peter McCue; Lawrence Chan; Bonita Falkner; Barry J Goldstein
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 10.  Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome.

Authors:  Cristina Lara-Castro; W Timothy Garvey
Journal:  Endocrinol Metab Clin North Am       Date:  2008-12       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.